[{"notes_id":"1_1212","category":"12","subcategory":"0","title":"Acute exacerbation of COPD","body":"Acute exacerbations of COPD are one of the most common reasons why people present to hospital in developed countries.<br \/><br \/>The most common infective causes of COPD exacerbations are:<br \/><ul><li>bacteria<ul><li><span class=\"concept\" data-cid=\"5077\"><i>Haemophilus influenzae<\/i> (most common cause)<\/span><\/li><li><i>Streptococcus pneumoniae<\/i><\/li><li><i>Moraxella catarrhalis<\/i><\/li><\/ul><\/li><li>respiratory viruses<ul><li>account for around 30% of exacerbations<\/li><li>human rhinovirus is the most important pathogen<\/li><\/ul><\/li><\/ul><br \/>Features<br \/><ul><li>increase in dyspnoea, cough, wheeze<\/li><li>there may be an increase in sputum suggestive of an infective cause<\/li><li>patients may be hypoxic and in some cases have acute confusion<\/li><\/ul><br \/>NICE guidelines from 2010 recommend the following:<br \/><ul><li>increase the frequency of bronchodilator use and consider giving via a nebuliser<\/li><li>give prednisolone 30 mg daily for <span class=\"concept\" data-cid=\"10968\">5 days<\/span><\/li><li>it is common practice for all patients with an exacerbation of COPD to receive antibiotics. NICE do not support this approach. They recommend giving oral antibiotics <span class=\"concept\" data-cid=\"7722\">'if sputum is purulent or there are clinical signs of pneumonia'<\/span><\/li><li>the BNF recommends one of the following oral antibiotics first-line: <span class=\"concept\" data-cid=\"6117\">amoxicillin or clarithromycin or doxycycline.<\/span><\/li><\/ul><br \/>Admission is recommended if any of the following criteria are met<br \/><ul><li>severe breathlessness<\/li><li>acute confusion or impaired consciousness<\/li><li>cyanosis<\/li><li>oxygen saturation less than 90% on pulse oximetry.<\/li><li>social reasons e.g. inability to cope at home (or living alone)<\/li><li>significant comorbidity (such as cardiac disease or insulin-dependent diabetes)<\/li><\/ul><br \/><br \/><h5 class='notes-heading'>Severe exacerbations requiring secondary care<\/h5><br \/>Oxygen therapy<br \/><ul><li>COPD patients are at risk of hypercapnia - therefore an initial oxygen saturation target of 88-92% should be used<\/li><li>prior to the availability of blood gases, use a 28% Venturi mask at 4 l\/min and aim for an oxygen saturation of 88-92% for patients with risk factors for hypercapnia but no prior history of respiratory acidosis<\/li><li>adjust target range to 94-98% if the pCO2 is normal<\/li><\/ul><br \/>Nebulised bronchodilator<br \/><ul><li>beta adrenergic agonist: e.g. salbutamol<\/li><li>muscarinic antagonists: e.g. ipratropium<\/li><\/ul><br \/>Steroid therapy as above<br \/><ul><li>IV hydrocortisone may sometimes be considered instead of oral prednisolone<\/li><\/ul><br \/>IV theophylline<br \/><ul><li>may be considered for patients not responding to nebulised bronchodilators<\/li><\/ul><br \/>Patients with COPD are prone to develop type 2 respiratory failure. If this develops then <span class=\"concept\" data-cid=\"7721\">non-invasive ventilation<\/span> may be used<br \/><ul><li>typically used for COPD with respiratory acidosis pH 7.25-7.35<ul><li>the BTS guidelines state that NIV can be used in patients who are more acidotic (i.e. pH < 7.25) but that a greater degree of monitoring is required (e.g. HDU) and a lower threshold for intubation and ventilation should be used<\/li><\/ul><\/li><li>bilevel positive airway pressure (BiPaP) is typically used with initial settings:<ul><li>Expiratory Positive Airway Pressure (EPAP): 4-5 cm H2O. Consider increasing EPAP if hypoxia despite adequate ventilation<\/li><li>Inspiratory Positive Airway Pressure (IPAP): RCP advocate 10 cm H20 whilst BTS suggest 12-15 cm H2O. <span class=\"concept\" data-cid=\"12533\">IPAP should be gradually increased if persistently high or rising pCO\u2082 with low pH (<7.30)<\/span>. As IPAP rises, need to monitor patient comfort\/tolerance, air leaks, gastric distension etc<\/li><\/ul><\/li><\/ul>","notes_hash":"9bf7c5c616032ad8ff893095d841dec2","knowledge_graph_node_id_link":1496,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1474\" data-linkid=\"1474\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1474\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">29<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1474\" data-linkid=\"1474\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1474\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">15<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng115\/chapter\/Recommendations\">2018 COPD guidelines<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/OHQK5PUTQ_0\" data-description=\"CPAP and Non-Invasive Ventilation in 5 minutes\" data-upvotes=\"28\" data-downvotes=\"3\" data-media=\"478\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/OHQK5PUTQ_0\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/OHQK5PUTQ_0\" data-description=\"CPAP and Non-Invasive Ventilation in 5 minutes\" data-upvotes=\"28\" data-downvotes=\"3\" data-media=\"478\">CPAP and Non-Invasive Ventilation in 5 minutes<\/a><\/td><\/tr><tr><td><span ><small>Nick Smith - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_839\" data-mediaid=\"839\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_839\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">28<\/span><button type=\"button\" style=\"\" id=\"media_dislike_839\" data-mediaid=\"839\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_839\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"5077":{"concept_text":"The most common organism causing infective exacerbations of COPD is <i>Haemophilus influenzae<\/i>","concept_percentile":"82"},"6117":{"concept_text":"Infective exacerbation of COPD: first-line antibiotics are amoxicillin or clarithromycin or doxycycline","concept_percentile":"27"},"7721":{"concept_text":"Acute exacerbation of COPD: BiPaP is indicated if type 2 respiratory failure develops despite medical therapy","concept_percentile":"94"},"7722":{"concept_text":"NICE only recommend giving oral antibiotics in an acute exacerbation of COPD in the presence of purulent sputum or clinical signs of pneumonia","concept_percentile":"79"}},"category_name":"Respiratory","subcategory_name":"","comment_count":9},"",[]]